Products Affected - Description
D.H.E. 45 injection, Valeant
1 mg/mL, 1 mL ampule, 10 count (NDC 66490-0041-01)
Dihydroergotamine Mesylate injection, Perrigo
1 mg/mL, 1 mL ampule, 5 count (NDC 00574-0850-05)
1 mg/mL, 1 mL ampule, 10 count (NDC 00574-0850-10)
Reason for the Shortage
Perrigo and Valeant did not provide a reason for the shortage.
There is insufficient supply for usual ordering.
Estimated Resupply Dates
- Perrigo has dihydroergotamine 1 mg/mL 1 mL ampules in 5 count and 10 count on allocation.
- Valeant has D.H.E. 45 1 mg/mL 1 mL ampules on back order and the company cannot estimate a release date.
February 16, January 6, 2017; December 19 and 14, November 22, October 5, September 2, August 1, July 13, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins